ENvue Medical Inc
FEED
8 hedge funds and large institutions have $215K invested in ENvue Medical Inc in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.05% less ownership
Funds ownership: 0.13% → 0.09% (-0.05%)
14% less capital invested
Capital invested by funds: $251K → $215K (-$36.2K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$24.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$12.2K |
| 3 |
VF
Virtu Financial
New York
|
+$11.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$54.8K |
| 2 |
Renaissance Technologies
New York
|
-$16.3K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$6.27K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$202 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $112K | -$54.8K | -813 | -32% |
|
|
2
Citadel Advisors
Miami,
Florida
| $25.9K | +$12.2K | +181 | +84% |
|
|
3
UBS Group
Zurich,
Switzerland
| $24.3K | +$24.4K | +361 | +2,579% |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $17.9K | – | – | – |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $13.4K | -$202 | -3 | -1% |
|
|
VF
6
Virtu Financial
New York
| $12K | +$11.9K | +176 | New |
|
|
TSS
7
Two Sigma Securities
New York
| $6.5K | -$6.27K | -93 | -48% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $3.57K | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $19 | – | – | – |
|
|
10
Renaissance Technologies
New York
| – | -$16.3K | -242 | Closed |
|
FEED Hedge Fund Activity: Q4 2024 in Review
8 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in ENvue Medical Inc (FEED) for Q4 2024, worth a combined $215K — down 14% from $251K a quarter earlier.
Fund positioning in FEED was balanced in Q4 2024: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $24.4K. The largest seller was Armistice Capital, cutting an estimated $54.8K.
- 8 institutional investors held ENvue Medical Inc (FEED) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $215K of ENvue Medical Inc stock for Q4 2024, down 14% quarter-over-quarter.
- 1 fund opened new ENvue Medical Inc positions in Q4 2024 and 1 closed out, a net change of 0 holders.
- The largest ENvue Medical Inc buyer in Q4 2024 was UBS Group, an estimated $24.4K added.
- The largest ENvue Medical Inc seller in Q4 2024 was Armistice Capital, an estimated $54.8K sold.
Based on aggregated 13F filings for Q4 2024.